Gillies Hunter has filed 37 insider transactions across 1 company since January 2024.
Most recent transaction: a option exercise of 6000 shares of Jade Biosciences, Inc. ($JBIO) on June 13, 2024.
Activity breakdown: 0 open-market purchases and 13 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 13, 2024 | Jade Biosciences, Inc. | $JBIO | Gillies Hunter | CHIEF MEDICAL OFFICER | M | Common Stock | 6000 | $2.14 | 11,602.0000 | 0 | 107.10% | 0.00% |
| June 13, 2024 | Jade Biosciences, Inc. | $JBIO | Gillies Hunter | CHIEF MEDICAL OFFICER | S | Common Stock | 6000 | $24.50 | 5,602.0000 | 0 | 51.72% | 0.00% |
| June 13, 2024 | Jade Biosciences, Inc. | $JBIO | Gillies Hunter | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 6000 | $0.00 | 83,510.0000 | 0 | 6.70% | 0.00% |
| May 17, 2024 | Jade Biosciences, Inc. | $JBIO | Gillies Hunter | CHIEF MEDICAL OFFICER | M | Common Stock | 4000 | $2.14 | 9,602.0000 | 0 | 71.40% | 0.00% |
| May 17, 2024 | Jade Biosciences, Inc. | $JBIO | Gillies Hunter | CHIEF MEDICAL OFFICER | S | Common Stock | 3914 | $21.07 | 5,688.0000 | 0 | 40.76% | 0.00% |
| May 17, 2024 | Jade Biosciences, Inc. | $JBIO | Gillies Hunter | CHIEF MEDICAL OFFICER | S | Common Stock | 86 | $21.86 | 5,602.0000 | 0 | 1.51% | 0.00% |
| May 17, 2024 | Jade Biosciences, Inc. | $JBIO | Gillies Hunter | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 4000 | $0.00 | 11,324.0000 | 0 | 26.10% | 0.00% |
| April 17, 2024 | Jade Biosciences, Inc. | $JBIO | Gillies Hunter | CHIEF MEDICAL OFFICER | M | Common Stock | 4000 | $1.74 | 7,251.0000 | 0 | 123.04% | 0.00% |
| April 17, 2024 | Jade Biosciences, Inc. | $JBIO | Gillies Hunter | CHIEF MEDICAL OFFICER | S | Common Stock | 3689 | $22.30 | 3,562.0000 | 0 | 50.88% | 0.00% |
| April 17, 2024 | Jade Biosciences, Inc. | $JBIO | Gillies Hunter | CHIEF MEDICAL OFFICER | S | Common Stock | 311 | $23.33 | 3,251.0000 | 0 | 8.73% | 0.00% |
| April 17, 2024 | Jade Biosciences, Inc. | $JBIO | Gillies Hunter | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 503 | $0.00 | 2,511.0000 | 0 | 16.69% | 0.00% |
| April 17, 2024 | Jade Biosciences, Inc. | $JBIO | Gillies Hunter | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 3497 | $0.00 | 539.0000 | 0 | 86.65% | 0.00% |
| March 28, 2024 | Jade Biosciences, Inc. | $JBIO | Gillies Hunter | CHIEF MEDICAL OFFICER | M | Common Stock | 9000 | $2.14 | 12,251.0000 | 0 | 276.84% | 0.00% |
| March 28, 2024 | Jade Biosciences, Inc. | $JBIO | Gillies Hunter | CHIEF MEDICAL OFFICER | S | Common Stock | 9000 | $29.50 | 3,251.0000 | 0 | 73.46% | 0.00% |
| March 28, 2024 | Jade Biosciences, Inc. | $JBIO | Gillies Hunter | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 9000 | $0.00 | 89,510.0000 | 0 | 9.14% | 0.00% |
| March 18, 2024 | Jade Biosciences, Inc. | $JBIO | Gillies Hunter | CHIEF MEDICAL OFFICER | M | Common Stock | 4000 | $1.74 | 7,251.0000 | 0 | 123.04% | 0.00% |
| March 18, 2024 | Jade Biosciences, Inc. | $JBIO | Gillies Hunter | CHIEF MEDICAL OFFICER | M | Common Stock | 3000 | $2.14 | 10,251.0000 | 0 | 41.37% | 0.00% |
| March 18, 2024 | Jade Biosciences, Inc. | $JBIO | Gillies Hunter | CHIEF MEDICAL OFFICER | S | Common Stock | 6387 | $25.81 | 3,864.0000 | 0 | 62.31% | 0.00% |
| March 18, 2024 | Jade Biosciences, Inc. | $JBIO | Gillies Hunter | CHIEF MEDICAL OFFICER | S | Common Stock | 613 | $26.40 | 3,251.0000 | 0 | 15.86% | 0.00% |
| March 18, 2024 | Jade Biosciences, Inc. | $JBIO | Gillies Hunter | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 4000 | $0.00 | 4,036.0000 | 0 | 49.78% | 0.00% |
| March 18, 2024 | Jade Biosciences, Inc. | $JBIO | Gillies Hunter | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 3000 | $0.00 | 98,510.0000 | 0 | 2.96% | 0.00% |
| March 7, 2024 | Jade Biosciences, Inc. | $JBIO | Gillies Hunter | CHIEF MEDICAL OFFICER | M | Common Stock | 8975 | $2.14 | 12,226.0000 | 0 | 276.07% | 0.00% |
| March 7, 2024 | Jade Biosciences, Inc. | $JBIO | Gillies Hunter | CHIEF MEDICAL OFFICER | S | Common Stock | 8975 | $24.50 | 3,251.0000 | 0 | 73.41% | 0.00% |
| March 7, 2024 | Jade Biosciences, Inc. | $JBIO | Gillies Hunter | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 945 | $0.00 | 15,324.0000 | 0 | 5.81% | 0.00% |
| March 7, 2024 | Jade Biosciences, Inc. | $JBIO | Gillies Hunter | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 8030 | $0.00 | 101,510.0000 | 0 | 7.33% | 0.00% |
| Feb. 23, 2024 | Jade Biosciences, Inc. | $JBIO | Gillies Hunter | CHIEF MEDICAL OFFICER | M | Common Stock | 511 | $1.74 | 3,762.0000 | 0 | 15.72% | 0.00% |
| Feb. 23, 2024 | Jade Biosciences, Inc. | $JBIO | Gillies Hunter | CHIEF MEDICAL OFFICER | S | Common Stock | 511 | $19.50 | 3,251.0000 | 0 | 13.58% | 0.00% |
| Feb. 23, 2024 | Jade Biosciences, Inc. | $JBIO | Gillies Hunter | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 511 | $0.00 | 3,014.0000 | 0 | 14.50% | 0.00% |
| Feb. 20, 2024 | Jade Biosciences, Inc. | $JBIO | Gillies Hunter | CHIEF MEDICAL OFFICER | M | Common Stock | 3489 | $1.74 | 6,740.0000 | 0 | 107.32% | 0.00% |
| Feb. 20, 2024 | Jade Biosciences, Inc. | $JBIO | Gillies Hunter | CHIEF MEDICAL OFFICER | S | Common Stock | 2591 | $20.11 | 4,149.0000 | 0 | 38.44% | 0.00% |
| Feb. 20, 2024 | Jade Biosciences, Inc. | $JBIO | Gillies Hunter | CHIEF MEDICAL OFFICER | S | Common Stock | 898 | $20.58 | 3,251.0000 | 0 | 21.64% | 0.00% |
| Feb. 20, 2024 | Jade Biosciences, Inc. | $JBIO | Gillies Hunter | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 2502 | $0.00 | 3,525.0000 | 0 | 41.51% | 0.00% |
| Feb. 20, 2024 | Jade Biosciences, Inc. | $JBIO | Gillies Hunter | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 987 | $0.00 | 8,036.0000 | 0 | 10.94% | 0.00% |
| Jan. 22, 2024 | Jade Biosciences, Inc. | $JBIO | Gillies Hunter | CHIEF MEDICAL OFFICER | A | Stock Option (Right to Buy) | 66586 | $0.00 | 66,586.0000 | 0 | 9999.99% | 0.00% |
| Jan. 17, 2024 | Jade Biosciences, Inc. | $JBIO | Gillies Hunter | CHIEF MEDICAL OFFICER | M | Common Stock | 4000 | $1.74 | 7,251.0000 | 0 | 123.04% | 0.00% |
| Jan. 17, 2024 | Jade Biosciences, Inc. | $JBIO | Gillies Hunter | CHIEF MEDICAL OFFICER | S | Common Stock | 4000 | $19.50 | 3,251.0000 | 0 | 55.16% | 0.00% |
| Jan. 17, 2024 | Jade Biosciences, Inc. | $JBIO | Gillies Hunter | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 4000 | $0.00 | 6,027.0000 | 0 | 39.89% | 0.00% |